Use caution when managing paclitaxel and taxotere infiltrations.
Goodman
M
M
Rush Cancer Institute, Chicago, IL, USA.
Stewart
I
I
Lydon
J
J
Blendowski
C
C
Barnicle
M
M
Petersen
J
J
Wickham
R
R
D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D000077143:Docetaxel; D004334:Drug Administration Schedule; D003875:Drug Eruptions / Q000451:nursing*; D006801:Humans; D007262:Infusions, Intravenous / Q000451:nursing*; D009369:Neoplasms / Q000188:drug therapy / Q000451:nursing*; D009730:Nursing Assessment; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel